PeptiDream Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PPTDF research report →
Companywww.peptidream.com
PeptiDream Inc. , a biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics. The company develops its products based on its Peptide Discovery Platform System, a drug finding platform for the development of peptides.
- CEO
- Patrick Crawford Reid
- IPO
- 2014
- Employees
- 621
- HQ
- Kawasaki, JP
Price Chart
Valuation
- Market Cap
- $902.02M
- P/E
- -42.84
- P/S
- 7.98
- P/B
- 3.08
- EV/EBITDA
- -54.40
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 42.42%
- Op Margin
- -24.91%
- Net Margin
- -18.74%
- ROE
- -6.88%
- ROIC
- -4.89%
Growth & Income
- Revenue
- $18.54B · -60.29%
- Net Income
- $-3,752,475,486 · -124.99%
- EPS
- $-29.80 · -125.72%
- Op Income
- $-4,978,820,652
- FCF YoY
- -169.05%
Performance & Tape
- 52W High
- $13.53
- 52W Low
- $7.02
- 50D MA
- $7.76
- 200D MA
- $10.09
- Beta
- 0.51
- Avg Volume
- 235
Get TickerSpark's AI analysis on PPTDF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our PPTDF Coverage
We haven't published any research on PPTDF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate PPTDF Report →